The administration of hepatitis B forces production domesticization to be very urgent

The administration of hepatitis B forces production domesticization to be very urgent
The shadow duckweed of fur coat is at present, the employing rate of antiviral medicine of the hepatitis B patient of our country is well below the world level, the patient's norm is therapeutic to lead to only account for 19%. Besides having insufficient understanding of disease, the high expenses for medicine are the key point. A medicines patent to that foreign enterprise is in the hand, could we permit producing the antiviral medicine of hepatitis B by force? Mr. Zhang is a chronic hepatitis B patient, need the antiviral treatment for a long time. But because the medicine price is expensive, he feels symptom takes a favorable turn and stops using medicine slightly, recuperate only by oneself. As Mr. Zhang 's saying, there is no money to take medicine, can only " guard and treat " . Insider analyze because foreign drugmaker monopolize, hepatitis B patient use medicine mainly Lammi costly definitely husband have, and often run out of goods. For this reason, should promote the production domesticization of this medicine as soon as possible. Foreign medicine unifies the whole country a patient can't bear the heavy load according to statistics, the number of people that the chronic B-mode hepatitis virus of our country infects is nearly 130 million, among them 30 million people suffer from chronic hepatitis B. The newest data reveal, the number of people that our country dies of hepatopathy every year is close to 500,000, the losses caused to society are up to 100 billion yuan. Our country is a enormous resisting hepatitis B and using medicine on the market too. In the face of this market, the international pharmacy giant demonstrates the great interest, enter into it one after another. Resisting the administration of hepatitis B at home at present is mainly dominated by transnational enterprises such as Ge Lan plain SmithKline, Bristol-Myers Squibb, Novartis and Luo,etc.. Transnational drugmakers are listed on our country new medicine the big cake fighting for the food and resisting the market of hepatitis B medicine in succession, though bring the hope against virus treatment to hepatitis B patient, bring an enormous economic pressure to them at the same time. The is determined as the example with Lammi, this medicine is that World Health Organization recommends the antiviral critical medicine which patients used of global hepatitis B. Must take according to quantity on time every day, can't be disconnected, abnormality will cause the internal virus to produced and able to bear nature while taking medicine, the patient will know the use cost higher Line two medicine. It is about 200 yuan that of a box and 14 Lammi holding it books prices. In fact, in terms of cost price, 1 the intersection of Lammi and it makes to be just 3000 more than, one the intersection of box and 14 medicines installed, cost prices are just about 4 yuans. Of Lammi of China's domestic sale makes personal value quite tallly, there is one reason: Have not realized production domesticization. Because of can't bear the intersection of expenses for medicine and heavy load, some patient have disconnected medicine midway or change dressings. The patent of foreign enterprise expects to permit relevant experts to think on hands, it is no doubt the most ideal method to substitute present foreign medicine with domestic new medicine by force, but because scientific research ability weak, most medicines on the the intersection of Chinese and domestic market belong to, model foreign the intersection of patent and overdue medicines. And is similar to Lammi the and fix such a medicine, the patent is in foreign pharmacy enterprise, we can't model yet. Our country belong to developing country, for those poor patients, the intersection of Lammi and it makes such medicine to be the luxury goods, can't afford to use. The expert points out recently, chronic hepatitis B is a progressive disease for a long time, when the patient carries on the antiviral treatment, medicines stop to request for agreement to doctor, in order to prevent the condition repeatedly and be able to bear nature. It influences disease control to change dressings, stop medicines without permission midway, it is able to bear nature to increase. But it will cause the condition to be repeated and worsen to able to bear the emergence of medicine. And expert propose after the intersection of Lammi and husband use definitely, most patients need to take all the life finally, only there are very little part of patientses that can stop medicines. And tolerance and economical pressure of taking medicine for a long time are with great influence on patient. The intersection of Lammi and it makes such a medicines to be thorny in question of production domesticization, also urgent. How to solve this awkward problem? The expert's view is, the country releases permitting it is the only ideal outlet that of Lammi at present domesticizes definitely by force. The expert explains, the pressure permission of what is called patent right, mean the competent authority of the national patent needn't get the permission of the patentee, allow the third person to use its patent directly through the administrative procedure, usually include producing, making the products or technological invention that patentees patented, and issue and implement legal system of the pressure licence of this patent to it. Permit that already there is precedent abroad under the environment of market economy by force, permit it is interests with intellectual property right of public health that play chess by force. Even till now, permit still the dispute in WTO by force. However, not lacking and starting the precedent permitted by force in the world, some developing countries such as Brazil, India, Thailand,etc. have released and permitted orders by force, even some developed countries have ever started this system too. U.S.A. is here " 9 11" After the incident, have ever received the anthracia virus " white powder " The influence of the incident, model medicines with the patent of Germany a pharmacy enterprise by force. In fact, start to permit, the law from WTO rule to our country all have a regulation early by force. After China joins WTO, " TRIPS (Trade-related aspects of intellectual property rights) protocol " has already produced engagement, and the domestic and related relevant intellectual property right regulation has already kept up with progressively. Have already stipulated that permits the system by force in China " patent law ", " patent permit implementing method by force " that State Intellectual Property Bureau release in succession later and it " involves public patent of health problem implement by force permitting waying " to be right specially The profit permits the system to make the detailed regulation by force. At present, the employing rate of antiviral medicine of the hepatitis B patient of our country is far lower than the world level, is only 19% that the patient standardizes the treatment to lead to accord with indication. Besides having insufficient understanding of disease, and the high treatment is taken it is the key point. Can think highly of disease, take for numerous the intersection of hepatitis B and patient up medicine, permit, walk the intersection of low price and route resist hepatitis B. Chained last year, " patent law " that our country revised increased such string: "For the public health purpose, to the medicines patenting, administrative department, patent of the State Council, can offer, make and arrive country or pressure of district that accord with the regulations of relevant international treaties that the People's Republic of China join export their Permission. "

|